TVTX•benzinga•
Piper Sandler Maintains Neutral on Travere Therapeutics, Raises Price Target to $22
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on November 14, 2024 by benzinga